仟源医药
(300254)
| 流通市值：19.15亿 | | | 总市值：20.56亿 |
| 流通股本：2.25亿 | | | 总股本：2.42亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 189,493,463.31 | 799,305,103.37 | 571,939,184.15 | 365,581,120.7 |
| 营业收入 | 189,493,463.31 | 799,305,103.37 | 571,939,184.15 | 365,581,120.7 |
| 二、营业总成本 | 176,063,821.72 | 803,213,426.31 | 583,637,093.87 | 391,271,113.45 |
| 营业成本 | 64,505,158.7 | 257,473,211.12 | 185,380,618.73 | 123,336,307.43 |
| 税金及附加 | 1,586,100.75 | 12,789,571.92 | 7,979,726.84 | 4,260,164.86 |
| 销售费用 | 66,773,310.16 | 331,954,112.72 | 239,903,789.55 | 162,246,284.16 |
| 管理费用 | 27,407,459.75 | 121,486,561.29 | 85,576,391.84 | 55,681,453.22 |
| 研发费用 | 12,048,160.13 | 49,970,320.87 | 39,070,730.56 | 23,227,216.66 |
| 财务费用 | 3,743,632.23 | 29,539,648.39 | 25,725,836.35 | 22,519,687.12 |
| 其中:利息费用 | 4,111,631.71 | 33,158,553.55 | 26,907,566.17 | 24,291,027.26 |
| 其中:利息收入 | 319,290.42 | 3,742,934.43 | 3,263,197.06 | 1,849,680.14 |
| 加:投资收益 | - | 20,882,415.76 | 236,009.23 | -266,236.74 |
| 资产处置收益 | 44,123.37 | 18,798,126.74 | -36,854.58 | -21,771.31 |
| 资产减值损失(新) | 1,214,994.18 | -6,550,310.36 | 39,129.58 | 447,225.39 |
| 信用减值损失(新) | 479,316.24 | 3,002,840.93 | 178,851.12 | 653,098.21 |
| 其他收益 | 3,267,569.7 | 7,929,414.69 | 4,358,130.06 | 2,038,760.07 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 18,435,645.08 | 40,154,164.82 | -6,922,644.31 | -22,838,917.13 |
| 加:营业外收入 | 7,658,399.02 | 16,751,349.1 | 12,260,245.02 | 10,054,420.24 |
| 减:营业外支出 | 47,747.14 | 1,626,350.75 | 1,249,492.97 | 1,205,684.86 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 26,046,296.96 | 55,279,163.17 | 4,088,107.74 | -13,990,181.75 |
| 减:所得税费用 | 1,100,613.08 | 6,552,881.91 | 3,778,023.34 | 3,752,837.8 |
| 六、净利润 | 24,945,683.88 | 48,726,281.26 | 310,084.4 | -17,743,019.55 |
| 持续经营净利润 | 24,945,683.88 | 48,726,281.26 | 310,084.4 | -17,743,019.55 |
| 归属于母公司股东的净利润 | 18,284,352.36 | 25,195,587.09 | -13,691,626.39 | -24,122,209.32 |
| 少数股东损益 | 6,661,331.52 | 23,530,694.17 | 14,001,710.79 | 6,379,189.77 |
| (一)基本每股收益 | 0.08 | 0.1 | -0.06 | -0.1 |
| (二)稀释每股收益 | 0.08 | 0.1 | -0.06 | -0.1 |
| 九、综合收益总额 | 24,945,683.88 | 48,726,281.26 | 310,084.4 | -17,743,019.55 |
| 归属于母公司股东的综合收益总额 | 18,284,352.36 | 25,195,587.09 | -13,691,626.39 | -24,122,209.32 |
| 归属于少数股东的综合收益总额 | 6,661,331.52 | 23,530,694.17 | 14,001,710.79 | 6,379,189.77 |
| 公告日期 | 2024-04-13 | 2024-03-19 | 2023-10-25 | 2023-08-05 |
| 审计意见(境内) | | 标准无保留意见 | | |